About LLINS Tech

Turn complex global registration routes into executable programs

LLINS Tech supports medical device and IVD companies across market selection, registration route design, master dossier planning, review issue diagnosis, representative services, technical documentation, quality systems, and clinical or performance evidence preparation.

What LLINS Tech is closer to

  • More than an advice desk, closer to a global market-entry execution partner
  • More than strategy, focused on whether evidence, documents, and review responses can close the loop
  • More than one-market support, built for reuse, representative maintenance, and post-market continuity

Positioning

Best suited for teams already moving toward international markets

LLINS Tech is especially useful when a product direction is clear but the market-entry route, dossier structure, review issue response, evidence planning, testing coordination, and representative work are still fragmented.

Coverage

China-based coordination with links into the EU, the US, and multi-market support resources

Current priority markets include CE/MDR/IVDR, FDA, Canada, Australia, Southeast Asia, and Turkey, with coordination around overseas testing, clinical support, and representative services.

How We Work

The work is phased, but ownership stays connected

Each stage has a clear output, but the overall program remains coordinated so the handoffs do not break the logic of the route.

01

Clarify the route

Align target markets, classification assumptions, applicable frameworks, reuse strategy, and project priorities.

02

Identify the gaps

Review technical files, testing results, quality systems, clinical or performance evidence, and review comments against target requirements.

03

Coordinate delivery

Move documentation, testing, second-opinion work, representative services, and submission readiness through one operating rhythm.

04

Maintain and extend

Support certificate maintenance, post-market obligations, and the next market expansion step.

Where We Fit Best

These situations usually create the strongest need

First-time market entry

The product direction is set, but the team has not yet formed a clear sequence across CE, FDA, Canada, Australia, or Southeast Asia.

Documents exist, but not as a coherent submission package

Technical files, testing, clinical or performance work, and QMS documentation are spread across different teams, and reuse across markets is unclear.

Longer-term regulatory coordination is needed

The project will run over multiple quarters and needs a partner who can stay close to review issues, representative maintenance, and expansion planning.

Contact points

  • Shanghai Room 1115, Building A, Xuhui Vanke Center, No.55 Ding'an Road
  • Hangzhou Room 1012, Tianheng Building, 1509 Binsheng Road, Binjiang District

Typical next step

  • Start with one discussion about the target market and current product state
  • Clarify the route, the evidence gaps, and the near-term priorities
  • Move into phased collaboration if needed

Go to contact